These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11251637

  • 1. Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries.
    Omura T, Matsumoto T, Nakae I, Takahashi M, Kinoshita M.
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):259-65. PubMed ID: 11251637
    [Abstract] [Full Text] [Related]

  • 2. Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide.
    Murohara T, Kugiyama K, Yasue H.
    J Vasc Res; 1996 Apr; 33(1):78-85. PubMed ID: 8603131
    [Abstract] [Full Text] [Related]

  • 3. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin.
    Matsumoto T, Takahashi M, Nakae I, Kinoshita M.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1247-53. PubMed ID: 8531088
    [Abstract] [Full Text] [Related]

  • 4. Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries.
    Matsumoto T, Okamura T, Kinoshita M, Toda N.
    Eur J Pharmacol; 1993 Jun 11; 237(1):31-7. PubMed ID: 8395391
    [Abstract] [Full Text] [Related]

  • 5. Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilators, nitroglycerin and sodium nitroprusside.
    Tao H, Zhang LM, Castresana MR, Newman WH, Shillcutt SD.
    J Neurosurg Anesthesiol; 1997 Jan 11; 9(1):58-64. PubMed ID: 9016442
    [Abstract] [Full Text] [Related]

  • 6. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A, Busse R, Bassenge E.
    Z Kardiol; 1989 Jan 11; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [Abstract] [Full Text] [Related]

  • 7. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
    Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmüller S, Walter U, Reichenspurner H, Meinertz T, Münzel T.
    Circulation; 2002 Mar 12; 105(10):1170-5. PubMed ID: 11889009
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
    Matsumoto T, Takahashi M, Omura T, Takaoka A, Liu Q, Nakae I, Kinoshita M.
    J Cardiovasc Pharmacol; 1997 Jun 12; 29(6):772-9. PubMed ID: 9234658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
    Henry PJ, Horowitz JD, Louis WJ.
    J Pharmacol Exp Ther; 1989 Feb 12; 248(2):762-8. PubMed ID: 2563771
    [Abstract] [Full Text] [Related]

  • 12. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
    Takaoka A, Nakae I, Takahashi M, Matsumoto T, Liu Q, Mitsunami K, Kinoshita M.
    J Cardiovasc Pharmacol; 1998 Feb 12; 31(2):231-9. PubMed ID: 9475264
    [Abstract] [Full Text] [Related]

  • 13. Differences between nitrates: role of isosorbide 2-mononitrate.
    Raddino R, Caretta G, Bonadei I, Teli M, Vizzardi E, Cas LD.
    J Cardiovasc Med (Hagerstown); 2010 Jul 12; 11(7):486-92. PubMed ID: 20414121
    [Abstract] [Full Text] [Related]

  • 14. Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries.
    Dou D, Zheng X, Qin X, Qi H, Liu L, Raj JU, Gao Y.
    Br J Pharmacol; 2008 Feb 12; 153(3):497-507. PubMed ID: 18037907
    [Abstract] [Full Text] [Related]

  • 15. Tolerance to nitroglycerin in vascular smooth muscle cells: recovery and cross-tolerance to sodium nitroprusside.
    Zhang LM, Castresana MR, Newman WH.
    Anesth Analg; 1994 Jun 12; 78(6):1053-9. PubMed ID: 8198258
    [Abstract] [Full Text] [Related]

  • 16. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
    Dou D, Ma H, Zheng X, Ying L, Guo Y, Yu X, Gao Y.
    Cardiovasc Res; 2010 Apr 01; 86(1):151-9. PubMed ID: 19939965
    [Abstract] [Full Text] [Related]

  • 17. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1989 Apr 01; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [Abstract] [Full Text] [Related]

  • 18. KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries.
    O'Rourke ST.
    J Cardiovasc Pharmacol; 1996 Jun 01; 27(6):831-7. PubMed ID: 8761850
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
    Donà G, Giuliani P, Cremonesi P, Passaro A, Stella P, Tursi F, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Jun 01; 26 Suppl 4():S59-66. PubMed ID: 8839228
    [Abstract] [Full Text] [Related]

  • 20. Nitrate tolerance impairs nitric oxide-mediated vasodilation in vivo.
    Laursen JB, Boesgaard S, Poulsen HE, Aldershvile J.
    Cardiovasc Res; 1996 May 01; 31(5):814-9. PubMed ID: 8763412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.